The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Oct. 21, 2019
Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Lonnie D. Shea, Ann Arbor, MI (US);

Robert S. Oakes, College Park, MD (US);

Aaron Morris, Ann Arbor, MI (US);

Kevin Hughes, Ann Arbor, MI (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61K 45/06 (2006.01); C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01); G01N 33/564 (2006.01); G01N 33/68 (2006.01); G01N 33/74 (2006.01); G01N 33/96 (2006.01); G06N 20/00 (2019.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); A61K 45/06 (2013.01); C12Q 1/68 (2013.01); C12Q 1/6883 (2013.01); G01N 33/53 (2013.01); G01N 33/5308 (2013.01); G01N 33/6863 (2013.01); G01N 33/74 (2013.01); G01N 33/96 (2013.01); G06N 20/00 (2019.01); C12Q 2600/158 (2013.01); G01N 2800/24 (2013.01); G01N 2800/285 (2013.01);
Abstract

Provided herein are methods of monitoring progression, regression, or stage of an AID in a subject, measuring a level of expression of a gene, an RNA, or a protein, or a combination thereof, in a sample obtained from a niche at the implantation site of a synthetic scaffold in the subject at a first time point and at a second time point, wherein the expression level measured at the first time point is compared to the expression level measured at the second time point, wherein the difference in the level of expression at the second time point relative to the level of expression at the first time point is indicative of progression, regression, or stage of the autoimmune disease. Related methods of detecting an AID, determining treatment for a subject with an AID, determining efficacy of an AID treatment, or treating an AID, are further provided.


Find Patent Forward Citations

Loading…